(Q34976095)

5 August 2017

title

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy (English)

1 reference

5 August 2017

1 reference

1 reference

Christopher A Pennell

Christopher A Pennell

11

0 references

Matthew A. Hunt

Matthew A Hunt

10

0 references

Robert M. Prins

Robert M Prins

6

0 references

Nicholas K Foreman

Nicholas K Foreman

9

0 references

Hideho Okada

7

Hideho Okada

1 reference

5 August 2017

8

Andrew M Donson

1 reference

5 August 2017

author name string

Christopher L Moertel

1

1 reference

5 August 2017

Junzhe Xia

2

1 reference

5 August 2017

Rebecca LaRue

3

1 reference

5 August 2017

Nate N Waldron

4

1 reference

5 August 2017

Brian M Andersen

5

1 reference

5 August 2017

Michael R Olin

12

1 reference

5 August 2017

publication date

16 December 2014

1 reference

Journal for Immunotherapy of Cancer

5 August 2017

published in

1 reference

5 August 2017

volume

2

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

46

1 reference

Creative Commons Attribution 2.0 Generic

5 August 2017

copyright license

start time

1 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

New strategies in lung cancer: translating immunotherapy into clinical practice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Tumour immunomodulation: mucins in resistance to initiation and maturation of immune response against tumours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Cellular constituents of immune escape within the tumor microenvironment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

CD200/CD200R paired potent inhibitory molecules regulating immune and inflammatory responses; Part I: CD200/CD200R structure, activation, and function.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Immunotherapy of cancer in 2012.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Molecular subgroups of medulloblastoma: the current consensus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Immune gene and cell enrichment is associated with a good prognosis in ependymoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Cancer stem cells, CD200 and immunoevasion

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

The role of myeloid cells in the promotion of tumour angiogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

CD200 is induced by ERK and is a potential therapeutic target in melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Immune resistance orchestrated by the tumor microenvironment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Ongoing first-line studies of epidermal growth factor receptor tyrosine kinase inhibitors in select patient populations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

CD200 and its receptors as targets for immunoregulation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the feto-maternal interface

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296547

Peptides of CD200 modulate LPS-induced TNF-alpha induction and mortality in vivo.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS40425-014-0046-9

Gene expression profiling of gliomas strongly predicts survival

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS40425-014-0046-9

Distribution of the Immune Inhibitory Molecules CD200 and CD200R in the Normal Central Nervous System and Multiple Sclerosis Lesions Suggests Neuron-Glia and Glia-Glia Interactions

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS40425-014-0046-9

Blockade of CD200 in the presence or absence of antibody effector function: implications for anti-CD200 therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25598973

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25598973

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S40425-014-0046-9

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference